GSK vs IBOC · P/E 13, $103.31B cap vs P/E 11, rev $435.0M
GlaxoSmithKline PLC ADR (GSK) versus International Bancshares Corporation (IBOC) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
International Bancshares Corporation (IBOC) is a banks - regional company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported IBOC revenue for 2026-06-30 was $435.0M. Net income was $198.0M. IBOC currently screens at market cap $4.35B and trailing P/E 10.7.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. IBOC currently screens at market cap $4.35B and trailing P/E 10.7.
Not investment advice. Open the GSK and IBOC stock pages for the full models.
Not investment advice.